Biomodal

3 known investors

biomodal develops a multi-modal genomic sequencing platform, including its 6-base sequencing and duet evoC products, that profiles epigenetic (5mC, 5hmC), genetic, and fragmentomics biomarkers from a single DNA sample. Its technology is applied to liquid biopsy workflows for applications such as cancer detection.